Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
EBIT Growth

    Back to All Ratios
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 48.5156.2082.53135.57-72.44

What is the latest EBIT Growth ratio of KILITCH DRUGS (INDIA) ?

The latest EBIT Growth ratio of KILITCH DRUGS (INDIA) is 48.51 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202448.51
Mar202356.20
Mar202282.53
Mar2021135.57
Mar2020-72.44

How is EBIT Growth of KILITCH DRUGS (INDIA) Trending?

Years EBIT Growth % Change
Mar2024 48.51
-13.68
Mar2023 56.2
-31.90
Mar2022 82.53
-39.12
Mar2021 135.57
Positive
Mar2020 -72.44 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare EBIT Growth ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹492.7 Cr -0.7% -6% -12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,246.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹147,119.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹116,805.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,554.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹93,192.0 Cr -0.9% -10% -11.3% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-0.7%

-6%

-12.9%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses